Skip to main content
. 2023 Jan 16;4(1):e195. doi: 10.1002/mco2.195

TABLE 4.

Clinical trials for disulfiram (DSF)‐based therapy

Condition or disease Drugs Study phase Status Identifier
Alcoholism Disulfiram Not applicable Unknown NCT00431262
Alcohol‐related disorders Disulfiram Not applicable Completed NCT00142844
Cocaine‐related disorders Naltrexone
Alcohol dependence Disulfiram Not applicable Completed NCT00721526
Anxiety disorder Lorazepam
Alcohol addiction Disulfiram Not applicable Completed NCT03212599
Alzheimer's disease
Recurrent GBM Disulfiram/copper Phase II Completed NCT03034135
Temozolomide
GBM Disulfiram/copper Phase II Not yet recruiting NCT01777919
Temozolomide
Metastatic breast cancer Disulfiram Phase II Recruiting NCT04265274
Chemotherapy
NSCLC Disulfiram Phase II/III Completed NCT00312819
Chemotherapy

Abbreviations: GBM, glioblastoma; NSCLC, non‐small cell lung cancers.

Source: clinicaltrials.gov website.